What is the mechanism of action for eptifibatide?
- Glycoprotein IIb/IIIa receptor antagonist, reversibly inhibiting platelet aggregation and adhesion
- Cyclooxygenase-1 (COX-1) inhibitor, irreversibly inhibiting platelet aggregation
- Increases the conversion of plasminogen to plasmin, promoting the breakdown of fibrin clots
- Direct thrombin inhibitor, preventing the conversion of fibrinogen to fibrin
- P2Y12 adenosine diphosphate (ADP) receptor antagonist, irreversibly inhibiting platelet aggregation and activation